Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 401-450 of 1329 result(s).
CYDY CytoDyn Inc
05/04/2025 8:34:26 AM
Thx jeff -- it's similar to canada' (1)
CYDY CytoDyn Inc
05/04/2025 8:32:53 AM
Dec. 2024, 36+/48+ & ESMO off-site (4)
CYDY CytoDyn Inc
05/04/2025 8:07:43 AM
Wish i wrote as clear as you & othe (1)
CYDY CytoDyn Inc
05/04/2025 8:03:01 AM
Invite, talk about LL /LL-PLS & MOA (5)
CYDY CytoDyn Inc
05/04/2025 7:46:26 AM
KC -- check this out: ESMO's other (12)
CYDY CytoDyn Inc
05/03/2025 8:35:27 PM
Look @ ESMO from KOL perspective. T (19)
CYDY CytoDyn Inc
05/02/2025 10:51:55 PM
Nov 16, 2021 -- Health Canada Autho (5)
CYDY CytoDyn Inc
05/02/2025 2:53:01 AM
From NASH patent application publis (7)
CYDY CytoDyn Inc
05/01/2025 8:48:24 AM
Leronlimab can/will create a new cl (5)
CYDY CytoDyn Inc
04/30/2025 11:22:09 PM
Now re-read Roza's discovery for Le (2)
CYDY CytoDyn Inc
04/30/2025 11:07:29 PM
2 hrs ago. The US Food and Drug Adm (3)
CYDY CytoDyn Inc
04/30/2025 10:03:19 PM
March letter & Follow-up: In the me (7)
CYDY CytoDyn Inc
04/30/2025 8:25:01 PM
Rough patient estimate: More than 4 (4)
CYDY CytoDyn Inc
04/30/2025 6:33:17 AM
Thank you Roza Ogurlu !! Presentati (6)
CYDY CytoDyn Inc
04/30/2025 1:29:41 AM
"This means that, on average, half (6)
CYDY CytoDyn Inc
04/29/2025 9:33:23 PM
July 2024 settlement. Today Cytodyn (2)
CYDY CytoDyn Inc
04/29/2025 8:28:57 PM
I would keep an eye on the BOD. Fro (3)
CYDY CytoDyn Inc
04/29/2025 6:23:40 PM
Safety hold -- how about a clawback (4)
CYDY CytoDyn Inc
04/29/2025 5:25:55 PM
and....not as
CYDY CytoDyn Inc
04/29/2025 5:25:27 PM
Think you're right --- only Dr. J a (1)
CYDY CytoDyn Inc
04/29/2025 4:10:43 PM
Gilead $200m fine is exactly what n (6)
CYDY CytoDyn Inc
04/29/2025 3:40:18 PM
Gilrad....caught crooked Hiv hand h (3)
CYDY CytoDyn Inc
04/29/2025 11:34:02 AM
Expecting FDA path to approval news (5)
CYDY CytoDyn Inc
04/29/2025 9:18:50 AM
& on that...with 12 month increment (2)
CYDY CytoDyn Inc
04/29/2025 8:38:55 AM
A second group ?? --" more than 48 (4)
CYDY CytoDyn Inc
04/27/2025 9:19:28 PM
Keep in mind Cytodyn is not the fun (4)
CYDY CytoDyn Inc
04/27/2025 9:14:57 PM
The Hiv-PLS is a joint collaboratio (1)
CYDY CytoDyn Inc
04/27/2025 5:45:49 PM
Why present Hiv FcRn now @ 1 year o (4)
CYDY CytoDyn Inc
04/27/2025 10:38:31 AM
May 15th: 1. We own all trial data. (6)
CYDY CytoDyn Inc
04/25/2025 9:15:37 PM
Project End Date 30-June-2025. " Su (6)
CYDY CytoDyn Inc
04/25/2025 11:22:43 AM
No SAE's. No drug - drug. No trial (5)
CYDY CytoDyn Inc
04/24/2025 10:50:03 AM
Each year, ESMO brings together ove (3)
CYDY CytoDyn Inc
04/24/2025 1:07:03 AM
We very possibly own the stadium & (3)
CYDY CytoDyn Inc
04/24/2025 12:17:47 AM
Don't overlook the tumor count pote (3)
CYDY CytoDyn Inc
04/23/2025 8:06:46 PM
Wouldn't THIS be a head spinner: Co (3)
CYDY CytoDyn Inc
04/23/2025 7:35:46 PM
ESMO abstracts are reviewed by the (3)
CYDY CytoDyn Inc
04/22/2025 12:16:28 AM
“My guess is that the FDA may rem (5)
CYDY CytoDyn Inc
04/21/2025 3:13:31 PM
His past interview is 100% in-line (6)
CYDY CytoDyn Inc
04/21/2025 11:33:20 AM
Nobody now @ FDA to protect a crook (1)
CYDY CytoDyn Inc
04/21/2025 11:20:17 AM
Riz...I think...someone said he's a (2)
CYDY CytoDyn Inc
04/21/2025 11:12:46 AM
You're dang right it is ---- " Maka (2)
CYDY CytoDyn Inc
04/21/2025 11:06:53 AM
"...will remove industry representa (3)
CYDY CytoDyn Inc
04/21/2025 10:58:55 AM
The beans are -- all crooked BP's j (4)
CYDY CytoDyn Inc
04/20/2025 10:36:18 PM
"The Food and Drug Administration w (6)
CYDY CytoDyn Inc
04/18/2025 9:26:46 AM
Testimonies 2021 & Prostate stage 4 (5)
CYDY CytoDyn Inc
04/16/2025 9:38:43 PM
Huge from WH on PBM middlemen: The (11)
CYDY CytoDyn Inc
04/14/2025 5:51:17 PM
Long-acting Leronlimab for cancer: (3)
CYDY CytoDyn Inc
04/09/2025 11:10:15 AM
https://www.yahoo.com/finance/news (2)
CYDY CytoDyn Inc
04/09/2025 12:42:53 AM
2023 Trump tariffs for cancer & pha (1)
CYDY CytoDyn Inc
04/09/2025 12:18:00 AM
April 9th, 2025: President Donald T (2)
Go to page:
  • << First
  • < Previous
  • 8
  • 9
  • Next >

Recent Articles

  • Recovery Predictions for the U.S. and California Economies Ahead
  • I&M Bank Unveils Innovative Mastercard Debit Cards for Customers
  • Deutsche Börse Teams Up with Chainlink for Market Data Innovation
  • NIO Inc. Achieves Record Deliveries in September 2025
  • Nike Faces Tariff Challenges Amid Kim Kardashian's Success
  • Senators Demand Action on Tesla's Self-Driving Safety Issues
  • Analyst Updates and Earnings Insights for Constellation Brands
  • Concerns Rise as Archer Health Faces Investigation Over Patient Data
  • Market Sentiment Rises as Dow Hits New Records This Month
  • Southland Holdings Secures Major Contracts, Stock Rallies 22%
  • Intellistake Technologies' Ambitious Move to Acquire SVH
  • SK Chemicals Showcases Innovative Solutions at K 2025 Expo
  • Kia America Celebrates Record Sales Performance in 2025
  • Pharma Equity Group Announces New Issuance of Convertible Loans
  • Cal-Maine Foods Set for Earnings Release with Analyst Updates
  • Discover How Wood Mackenzie is Shaping Energy and Mining Insights
  • Bitwise Launches Avalanche Staking ETP for Enhanced Crypto Growth
  • Wealth Invest Updates Prospectus for Optimal Stabil Fund
  • Updated Prospectus for Coop Savings Investment Fund Released
  • Updated Investor Information from Kapitalforeningen Wealth Invest
  • Stay Informed: PayPoint Plc's Recent Managerial Transactions
  • Nokia's Innovations in AI-Driven Data Center Networking
  • Revolutionizing Solar Efficiency: The Fluke GFL-1500's Impact
  • Nordea Invest Unveils Updated Prospectus for Investors
  • Trident Resources Unveils Exciting Gold Exploration Plans
  • Tessellate Bio Welcomes Dr. Katie Chapman as New CSO
  • Potential Impacts of Government Shutdowns on Economy and Markets
  • Stocks to Monitor: Nike, Conagra Brands, and Others This Week
  • Compliancy Group Shares Insights on Healthcare Risk Assessments
  • Clarivate Innovates with AI for Enhanced Patent Analysis
  • Taiwan Declines U.S. Semiconductor Production Split Proposal
  • Innovative Solutions for Enhanced Meat Quality in Europe
  • Hill's Pet Nutrition Hosts Global Symposium for Senior Pet Care
  • Geopolitical Volatility and Cyber Risks: Insights from Aon's Survey
  • Huawei Launches 100,000 Watch Faces to Inspire Global Designers
  • Max Einhorn Explores AI in Filmmaking and Storytelling
  • MD Logistics Transforms Key Facility into cGMP-Compliant Hub
  • 1664 Beer Welcomes Robert Pattinson as Global Ambassador
  • Kostklip® Rebrands for a Modern Retail Experience
  • Market Reactions to Government Shutdown: Insights on Bitcoin and Ethereum
  • Exploring Robo.ai's Major Investment and Market Impact
  • Lunawood LLC Launches Innovative Wood Facility in Georgia
  • InstrumentiX Gains Strategic Investment from Keysight Technologies
  • Future Growth of 3D Scanners in Manufacturing and Healthcare
  • BTCC's Bold Plans for Workforce Expansion at TOKEN2049 Event
  • Capgemini's Strategic Acquisition to Advance Nuclear Solutions
  • Campine NV Completes Strategic Acquisition to Enhance Growth
  • Sampo Group Transitions Executive Committee Leadership Roles
  • Leadership Change: Andrew Obenshain Takes Helm at Inventiva
  • Key Insights on Tryg Forsikring A/S Callable Bond Issue
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site